Storia in 3 fonti

Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances

Raccontata da

morningstar.com

lecho.be

endpoints.news

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo17 g fa

Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances

originale

endpoints.news15 g fa

Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist

Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics.

Leggi questa versione → originale

lecho.be16 g fa

Michel Detheux nommé CEO de Muna Therapeutics, spécialiste du traitement contre Alzheimer

Le Belge Michel Detheux, ex-patron d’Iteos Therapeutics, la biotech aujourd’hui disparue, prend la tête de Muna Therapeutics. Une société dano-belge qui travaille au développement d’une thérapie contre la maladie…

Leggi questa versione → originale

Timeline cronologica

martedì 30 giugno 2026·morningstar.com
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
martedì 30 giugno 2026·lecho.be
Michel Detheux nommé CEO de Muna Therapeutics, spécialiste du traitement contre Alzheimer
Le Belge Michel Detheux, ex-patron d’Iteos Therapeutics, la biotech aujourd’hui disparue, prend la tête de Muna Therapeutics. Une société dano-belge qui travaille au développement…
giovedì 2 luglio 2026·endpoints.news
Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist
Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics.